• Return to Headlines

Relatively Good Performance Detected in Shares of Medivation in the Biotechnology Industry (MDVN, GHDX, THRX, NPSP, TRGT)

Written on Fri, 11/04/2011 - 4:14am
By David Diaz

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the potential to outperform.
Medivation (NASDAQ:MDVN) ranks first with a gain of 140.47%; Genomic Health (NASDAQ:GHDX) ranks second with a gain of 8%; and Theravance (NASDAQ:THRX) ranks third with a gain of 6.53%.
NPS Pharmaceuticals (NASDAQ:NPSP) follows with a gain of 4.95% and Targacept (NASDAQ:TRGT) rounds out the top five with a gain of 3.67%.
SmarTrend currently has shares of Targacept in an Uptrend and issued the Uptrend alert on September 20, 2011 at $16.84. The stock has risen 14% since the Uptrend alert was issued.

Keywords: Medivation relative performance

Ticker(s): MDVN GHDX THRX NPSP TRGT

Contact David Diaz



Smartrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.mysmartrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at http://www.mysmartrend.com/morning-call-newsletter-signup.